Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 15/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

100%

2 of 2 completed trials have results

Key Signals

1 recruiting2 with results

Enrollment Performance

Analytics

N/A

1(50.0%)

Phase 4

1(50.0%)

2Total

N/A(1)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials

NCT06847750Enrolling By Invitation

Elastography Ultrasound in Localized Scleroderma (Morphea) Study

Role: collaborator

NCT02418442Recruiting

Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry

Role: collaborator

NCT05693571Not ApplicableEnrolling By Invitation

Engagement in CHildhood-Onset Systemic Lupus

Role: collaborator

NCT02593006Completed

Start Time Optimization of Biologics in Polyarticular JIA

Role: collaborator

NCT00589628Phase 4Completed

Multi Center Prospective Registry of Infliximab Use for Childhood Uveitis

Role: collaborator

All 5 trials loaded